MOXIFLOXACIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Moxifloxacin Hydrochloride patents expire, and what generic alternatives are available?
Moxifloxacin Hydrochloride is a drug marketed by Alembic, Apotex, Epic Pharma Llc, Eugia Pharma, Gland Pharma Ltd, Indoco, Lupin Ltd, Mylan, Upsher Smith Labs, Fresenius Kabi Usa, Aurobindo Pharma Ltd, Chartwell Rx, Crossmedika Sa, Dr Reddys, Hetero Labs Ltd V, MSN, Sunshine, Teva Pharms Usa, Torrent, and Mylan Labs Ltd. and is included in twenty-two NDAs.
The generic ingredient in MOXIFLOXACIN HYDROCHLORIDE is moxifloxacin hydrochloride. There are eighteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the moxifloxacin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Moxifloxacin Hydrochloride
A generic version of MOXIFLOXACIN HYDROCHLORIDE was approved as moxifloxacin hydrochloride by TEVA PHARMS USA on February 18th, 2014.
Summary for MOXIFLOXACIN HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 20 |
NDAs: | 22 |
Finished Product Suppliers / Packagers: | 32 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 474 |
Patent Applications: | 1,594 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for MOXIFLOXACIN HYDROCHLORIDE |
What excipients (inactive ingredients) are in MOXIFLOXACIN HYDROCHLORIDE? | MOXIFLOXACIN HYDROCHLORIDE excipients list |
DailyMed Link: | MOXIFLOXACIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MOXIFLOXACIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ministry of Health, France | Phase 3 |
Assistance Publique Hopitaux De Marseille | Phase 3 |
Hôpital Necker-Enfants Malades | Phase 3 |
Pharmacology for MOXIFLOXACIN HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MOXIFLOXACIN HYDROCHLORIDE
Paragraph IV (Patent) Challenges for MOXIFLOXACIN HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
MOXEZA | Ophthalmic Solution | moxifloxacin hydrochloride | 0.5% | 022428 | 1 | 2012-02-29 |
VIGAMOX | Ophthalmic Solution/Drops | moxifloxacin hydrochloride | 0.5% | 021598 | 1 | 2005-12-22 |